These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4964444)

  • 1. [Experimental data on the therapeutic action of B. subtilis in pulmonary tuberculosis].
    Kagramanov AI; Makarevich NM
    Sov Med; 1966 Jan; 29(1):68-73. PubMed ID: 4964444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Bacillus subtilis on the course of experimental tuberculosis in guinea pigs evoked by the strain of drug-resistant bacilli].
    Fafrowicz B
    Przegl Lek; 1969 Apr; 25(4):386-8. PubMed ID: 4978153
    [No Abstract]   [Full Text] [Related]  

  • 3. Gammaglobulin in experimental tuberculosis and its therapeutic application in pulmonary tuberculosis.
    Turczynowski R
    Pol Med Sci Hist Bull; 1970 Jan; 13(1):40-2. PubMed ID: 4190037
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of Bac. subtilis for the treatment of pulmonary tuberculosis and other pneumopathies].
    Fam NGOK TKHAK ; Le VAN TKHO ; Koan DING TRUNG ; Hguen VAN GUA ; Buu GUNG ; Nguen KIM PKHAT
    Sov Med; 1965 Dec; 28(12):53-7. PubMed ID: 4959833
    [No Abstract]   [Full Text] [Related]  

  • 5. [Subtilis therapy in pulmonary diseases. I. Bacillus subtilis in the treatment of pulmonary tuberculosis].
    Pham Ngoc Thach
    Sem Ther; 1964 Dec; 40(10):607-13. PubMed ID: 4964177
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of Bacillus subtilis on the course of experimental tuberculosis in guinea pigs evoked by the strain of drug-resistant bacilli].
    Fafrowicz B
    Ann Acad Med Stetin; 1969; 15():345-76. PubMed ID: 4985053
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and experimental study on the mode of action of pneumoperitoneum].
    Guillermand J; Tizzani RJ
    Rev Tuberc Pneumol (Paris); 1965; 29(5):445-57. PubMed ID: 5319911
    [No Abstract]   [Full Text] [Related]  

  • 8. The safety of Bacillus subtilis and Bacillus indicus as food probiotics.
    Hong HA; Huang JM; Khaneja R; Hiep LV; Urdaci MC; Cutting SM
    J Appl Microbiol; 2008 Aug; 105(2):510-20. PubMed ID: 18312567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ambulation in experimental tuberculosis.
    Viswanathan R
    Indian J Med Res; 1966 Oct; 54(10):910-4. PubMed ID: 4166937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guinea pigs infected by bacterial dust aerosol of Bacillus tuberculosis].
    Wu Z; Wang Z; Wan S
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):313-5, 320. PubMed ID: 8762489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphological changes in the air-blood barrier in pulmonary tuberculosis treated with a permanent magnetic field].
    Stasiuk GA; Bodnar IaIa
    Vrach Delo; 1984 Jul; (7):52-4. PubMed ID: 6475021
    [No Abstract]   [Full Text] [Related]  

  • 12. [Wide range of the use of natural lipases and esterases to inhibit Mycobacterium tuberculosis].
    Annenkov GA; Klepikov NN; Martynova LP; Puzanov VA
    Probl Tuberk Bolezn Legk; 2004; (6):52-6. PubMed ID: 15315135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of bacterial populations in experimental destructive pulmonary tuberculosis under treatment].
    Golişevskaia V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(2):111-4. PubMed ID: 6264575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic asthma in guinea pigs.
    Yagura T; Miyagawa T; Yamamura Y
    Folia Allergol (Roma); 1970; 17(4):422-3. PubMed ID: 4989780
    [No Abstract]   [Full Text] [Related]  

  • 15. Study on the cleaning of tuberculous cavity by artificial contamination. I. Experiments on Bacillus subtilis.
    TSUJI S; NAMIKAWA Y
    Acta Tuberc Jpn; 1951 Jun; 1(1):34-8. PubMed ID: 12985446
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
    Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
    Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
    Yan BS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of hypoglycemic drugs on results of treatment with nicotinic acid hydrazide in experimental tuberculosis in guinea pigs, caused by Mycobacterium tuberculosis of low resistance to INH].
    Kulig A
    Patol Pol; 1968; 19(1):237-41. PubMed ID: 4968014
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental and clinico-therapeutic research with terizidone in tuberculosis].
    Mariani B; Bisetti A; Velluti G
    Minerva Med; 1968 May; 59(42):2445-58. PubMed ID: 5653336
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening of Bacillus strains as potential probiotics and subsequent confirmation of the in vivo effectiveness of Bacillus subtilis MA139 in pigs.
    Guo X; Li D; Lu W; Piao X; Chen X
    Antonie Van Leeuwenhoek; 2006 Aug; 90(2):139-46. PubMed ID: 16820971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.